A prospective randomized study of Chop versus Chop plus Alpha-2B interferon in patients with Intermediate and High Grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study
F. J. Giles*, J. Shan, S. H. Advani, H. Akan, I. Aydogdu, Z. Aziz, H. A. Azim, P. P. Bapsy, F. Buyukkececi, B. Chaimongkol, P. M. Chen, S. K. Cheong, B. Ferhanoglu, R. Hamza, H. M. Khalid, T. Intragumtornchai, S. W. Kim, S. Y. Kim, H. Koc, L. KumarR. Kumar, K. I. Lei, A. Lekhakula, A. Muthalib, M. Patel, V. P. Poovalingam, W. Prayoonwiwat, F. Rana, A. H. Reksodiputro, P. Ruff, T. G. Sagar, A. P. Schwarer, H. S. Song, C. W. Suh, C. Suharti, I. Supindiman, G. Y. Tee, T. Thamprasit, A. H. Villalon, N. R. Wickham, J. E. Wong, A. Yalcin, S. Jootar
Dive into the research topics of 'A prospective randomized study of Chop versus Chop plus Alpha-2B interferon in patients with Intermediate and High Grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study'. Together they form a unique fingerprint.